Category Archives: GCD-0032

We could not have asked for better weather for Lisa’s birthday. The sun is out and the temperature should hit near 70! Perfect for a soak in the hot tub while enjoying the view of the mountain with its trees … Continue reading →

A wonderful spring is on its way to the Granite State. The igloo has melted, the lake has thawed, and Lisa continues to respond well to her current treatment. She just started the fifth, 28-day cycle of GDC-0032 and the … Continue reading →

On February 22, 2012, the FDA approved Kadcyla, formerly know as T-DM1, for treatment of patients with HER2 positive breast cancer. Kadcyla is new type of targeted cancer treatment known as an antibody conjugate. It combines the antibody trastuzamab (Herceptin) … Continue reading →

And good riddance to 2012! With steadfast fortitude and an unrelenting, positive attitude, Lisa survived that brutal year. Thanks to her talented medical team and the efficacy of the cutting edge treatments she has started out 2013 feeling better and … Continue reading →

Lisa has been taking GDC-0032 since last Friday (12/14/2012) and is feeling pretty good. GDC-0032 is a new drug in the fight against cancer. It works by blocking the PIK3 protein, which helps cancer cells grow. She is receiving this … Continue reading →

Just a quick update. After a one night stay at the hospital and lots of IV fluids, Lisa is back home. Yesterday afternoon she was able to eating solid food without a problem so there was no reason to keep … Continue reading →

Seasons change and so do cancer treatments. Lisa had a good run with T-DM1, a total of nine treatments over a six-month period, but the time has come for a change. T-DM1* worked well for Lisa, however, her CT scans … Continue reading →